Radioimmunoassay Detects the Frequent Occurrence of Autoantibodies to the Mr 65,000 Isoform of Glutamic Acid Decarboxylase in Japanese Insulin-Dependent Diabetes

References

• Rossini A A., Greincr D L., Friedman H P., Mordes J P. Immunopathogencsis of diabetes mellitus. Diabetes Reviews 1993; 1: 43–75
   Google Scholar
• Palmer J P. Predicting 1DDM: use of humoral immune markers. Diabetes Reviews 1993; 1: 104–115
   Google Scholar
• Baekkeskov S., Nielsen J H., Marner B., Bilde T., Ludvigs-Son J., Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature (Lond) 1982; 298: 167–169
   PubMed Web of Science ®Google Scholar
• Baekkeskov S., Aanstoot H J., Cristgau S., Reetz A., Solim-Ena M., Cascalho M, Folli F., Richter-Olescn H., De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (Lond) 1990; 347: 151–156
   PubMed Web of Science ®Google Scholar
• Karlsen A E., Michclsen B K., Petersen J K., Hagopian W A., Grubin C E., Boel E., Madsen O., Stenger D P., Lernmark Å. Glutamic acid decarboxylase: an autoantigen in insulin-dependent diabetes mellitus. Diabetes, Nutrition and Metabolism 1992; 5: 151–154
   Google Scholar
• Briel G., Gylfe E., Hellman B., Neuhoff V. Microdeter-mination of free amino acids in pancreatic islets isolated from obese hyperglycemic mice. Acta Physiol. Scand. 1972; 84: 247–253
   PubMedGoogle Scholar
• Okada Y., Taniguchi H., Shimada C. High concentrations of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma. Science 1976; 194: 620–622
   PubMed Web of Science ®Google Scholar
• Hagopian W A., Michelsen B., Karlsen A E., Larsen F., Moddy A., Grubin C E., Rowe R. Petersen J., McEvoy R. and Lernmark A. Autoantibodies in insulin-dependent diabetes primarily recognize the Mr 65,000 rather than the Mr 67,000 isoform of glutamic acid decarboxylase. Diabetes 1993; 42: 631–636
   PubMed Web of Science ®Google Scholar
• Velloso L A., Kampe O., Hallberg A., Christmanson L., Bctsholtz C., Karlsson F A. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J. Clin. Invest. 1993; 91: 2084–2090
   PubMed Web of Science ®Google Scholar
• Seissler J., Amann J., Mauch L, Haubruck H., Wolfahrt S., Bieg S., Richter W., Holl R., Heinze E., Northemann W., Schcrbaum W A. Prevalence of autoantibodies to the 65-and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 1993; 92: 1394–1399
   PubMed Web of Science ®Google Scholar
• Petersen J S., Hejnaes K R., Moody A., Karlsen A E., Marshall M O., Hoier-Madsen M., Boel E., Michelsen B K., Dyrberg T. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994; 43: 459–467
   PubMed Web of Science ®Google Scholar
• Karlsen A E., Hagopian W A., Petersen J S., Boel E., Dyrberg T., Grubin C E., Michelsen B K., Madsen O D., Lernmark Å. Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-Mr autoantibodies. Diabetes 1992; 41: 1355–1359
   PubMed Web of Science ®Google Scholar
• Baekkeskov S., Landin-Olsson M., Kristensen J K., Srikanta S., Bruining G J., Mandrup-Poulsen T., De Beaufort C, Soeldner J S., Eisenbarth G., Lindgrcn F., Sundkvist G., Lernmark A. Antibodies to a Mr 64,000 human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J. Clin. Invest. 1987; 79: 926–934
   PubMed Web of Science ®Google Scholar
• Baekkeskov S., Dyrbcrg T., Lernmark Å. Autoantibodies to a 64-Kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science (Wash. DC) 1984; 224: 1348–1350
   PubMed Web of Science ®Google Scholar
• Atkinson M A., Maclarcn N K. Autoantibodies in nonobese diabetic mice immunoprecipitate 64,000-Mr islet antigen. Diabetes 1988; 37: 1587–1590
   PubMedGoogle Scholar
• Karlsen A E., Hagopian W A., Grubin C E., Dube S., Distechc CM., Adler D A., Bärmeier H., Mathewes S., Grant F J., Foster D., Lernmark Å. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc. Natl Acad. Sci. USA 1991; 88: 8337–8341
   PubMed Web of Science ®Google Scholar
• Bu D-F., Erlander M G., Hitz B C., Tillakaratne N J.K., Kaufman D L., Wagner-McPhcrson G B., Evans G A., Tobin A J. Two human glutamate decarboxylase, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc. Natl Acad. Sci. USA 1992; 89: 2115–2119
   PubMed Web of Science ®Google Scholar
• Bu D-F., Tobin A J. The exon-intron organization of the genes (GAD1 and GAD2) encoding two human glutamate decarboxylases (GAD67 and GAD65) suggests that they derive from a common ancestral GAD. Genomics 1994; 21: 222–228
   PubMed Web of Science ®Google Scholar
• Petersen J S., Russel S., Marshall M O., Kofod H., Buschard K., Cambon N., Karlsen A E., Boel E., Hagopian W A., Hejnaes K R., Moody A., Dyrberg T., Lernmark A., Madsen O D., Michelsen B. Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 1993; 42: 484–495
   PubMedGoogle Scholar
• Solimena M., Folli F., Aparisi R., Pozza G., DeCamilli P. Autoantibodies to GABA-ergic neurons and pancreatic P-cells in Stiff-man syndrome. N. Engl. J. Med. 1990; 322: 1555–1560
   PubMed Web of Science ®Google Scholar
• Genovese S., Wagner R., Bonifacio E., Bosi E., Dean B M., McNally J M., Foulis A K., Bottazzo G F. Absence of immune abnormalities in the pancreas of non-diabetic patients with long-standing GAD-antibodies. Diabetologia 1992; 35
   PubMedGoogle Scholar
• Serjeanston S W., Kohonen-Corish M R.J., Rowley M J., Mackay I R., Knowles W., Zimmet P. Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 996–1001
   PubMedGoogle Scholar
• Thomson G., Robinson W P., Kuhner M K., Joe S., Mac-Donald M J., Gottschall J L., Barbosa J., Rich S., Bertrams J., Baur M P., Partanen J., Tait B D., Schober E., Mayr W R., Ludvigsson J., Lindbolm B., Farid N R., Thompson C., Deschamps I. Modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am. J. Hum. Genet. 1988; 43: 799–816
   PubMed Web of Science ®Google Scholar
• Todd J A., Bell J I., McDevitt H O. HLA-DQP gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature (Lond.) 1987; 329: 599–604
   PubMed Web of Science ®Google Scholar
• Hawkins B R., Lam K S.L., Ma J T.C., Low L C.K., Cheung P T., Serjeantson S W., Yeung R T.T. Strong association of HLA-DR3/DRw9 heterozygosity with early-onset insulin-dependent diabetes mellitus in Chinese. Diabetes 1987; 36: 1297–1300
   PubMedGoogle Scholar
• Aparicio J M.R., Wakisaka A., Takada A., Matsura N., Aizawa M. HLA-DQ system and insulin-dependent diabetes mellitus in Japanese: does it contribute to the development of IDDM as it does in Caucasians?. Immunogenetics 1988; 28: 240–46
   PubMed Web of Science ®Google Scholar
• Awata T., Kuzuya T., Matsuda A., Iwamoto Y., Kanazawa Y., Okuyama M., Juji T. High frequency of aspartic acid at position 57 of the HLA-DQp chain in Japanese IDDM patients and nondiabetic subjects. Diabetes 1990; 39: 226–229
   PubMedGoogle Scholar
• Kawasaki E., Takino H., Mayumi Y., Uotani S., Matsumoto K, Takao Y., Yamaguchi Y., Akazawa S., Nagataki S. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994; 43: 80–86
   PubMedGoogle Scholar
• Kobayashi T., Nakanishi K. Natural history of type 1 diabetes mellitus and slowly progressive insulin-dependent diabetes mellitus. J. Japn. Diabetes Soc. 1987; 30: 1152–1154
   Google Scholar
• Kobayashi T., Tamemoto K., Nakanishi K., Kato N., Okubo M., Kajio H., Sugimoto T., Murase T., Kosaka K. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 1993; 16: 780–788
   PubMed Web of Science ®Google Scholar
• Grubin C E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W A., Li L., Karlsen A E., Boel E., Michelsen B., Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344–350
   PubMed Web of Science ®Google Scholar
• Michelsen B K., Petersen J S., Boel E., Moldrup A., Dyrberg T., Madsen O D. Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus. Proc. Natl Acad. Sci. USA 1991; 88: 8754–8758
   PubMedGoogle Scholar
• Bonifacio E., Lernmark Å, Dawkins R L. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J. Immunol. Methods 1980; 106: 83–88
   Google Scholar
• Lernmark Å, Molenaar J L., van Beers W A.M., Yamaguchi Y., Nagataki S., Ludvigsson J., McLaren N K. The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. Diabetologia 1991; 34: 534–535
   PubMed Web of Science ®Google Scholar
• Hagopian W A., Karlsen A E., Gottsäter A., Landin-Olsson M., Grubin C E., Sundkvist G., Petersen J S., Boel E., Dyrberg T., Lernmark Å. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J. Clin. Invest. 1993; 91: 368–374
   PubMed Web of Science ®Google Scholar
• Schmidei R S., Colman P G., Bonifacio E., Bottazzo G F., Harrison L C. and participating laboratories. High level of concordance between assays for glutamic acid decarboxylase antibodies: the first International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes 1994; 43: 1005–1009
   PubMedGoogle Scholar
• Bonifacio E., Bingley P J., Shattock M. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335: 147–149
   PubMed Web of Science ®Google Scholar
• Ziegler A G., Ziegler R., Vardi P., Jackson R A., Soeldner J S., Eisenbarth G S. Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes 1989; 38: 1320–1325
   PubMed Web of Science ®Google Scholar
• Atkinson M A., Maclaren N K, Scharp D W., Lacy P E., Riley W J. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet. 1990; 335: 1357–1360
   PubMed Web of Science ®Google Scholar
• Christie M., Landin-Olsson M., Sundkvist G., Dahlquist G., Lernmark A., Baekkeskov S. Antibodies to a Mr 64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia 1988; 31: 597–602
   PubMed Web of Science ®Google Scholar
• Bärmeier H., McCulloch D K., Neifing J L., Warnock G., Rajotte R V., Palmer J P., Lernmark Å. Risk for developing Type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies. Diabetologia 1991; 34: 727–733
   PubMed Web of Science ®Google Scholar
• Rowley M J., McKay I R., Chen Q Y., Knowles W J., Zimmet P Z. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 1992; 41: 548–551
   PubMed Web of Science ®Google Scholar
• Thivolet C H., Tappaz M., Durand A., Petersen J., Stefa-Nutti A., Chatelain P., Vialettes P., Scherbaum W., Orgiazzi J. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 570–576
   PubMedGoogle Scholar
• Zimmet P Z., Rowley M J., Mackay I R., Knowles W J., Chen Q Y., Chapman L H., Serjeantson S W. The ethnic distribution of antibodies to glutamic acid decarboxylase: presence and levels in insulin-dependent diabetes mellitus in Europid and Asian subjects. J. Diabetic Complications 1993; 7: 1–7
   Google Scholar
• Schmidli R S., DeAizpurua H J., Harrison L C., Colman P G. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile. J. Autoimmunity 1994; 7: 55–66
   PubMedGoogle Scholar
• Christie M., Delovitch T L. Persistence of antibodies to a 64,000-Mr islet cell protein after onset of type I diabetes. Diabetes 1990; 39: 653–659
   PubMed Web of Science ®Google Scholar
• Tuomi T., Groop L C., Zimmet P Z., Rowley M J., Knowles W., Mackay I R. Antibodies to glutamic acid decarboxylase reaveal latent autoimmune diabetes mellitus in adults with a non-insulin dependent onset of disease. Diabetes 1993; 42: 359–362
   PubMed Web of Science ®Google Scholar
• Gianani R., Pugliese A., Bonner-Weir S., Shiffrin A J., Soeldner J S., Erlich H., Awdeh Z., Alper C A., Jackson R A., Eisenbarth G S. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 1992; 41: 347–353
   PubMed Web of Science ®Google Scholar